Search

Jeffrey O Jackson

from Galloway, NJ
Age ~65
Get Report
Also known as:
Jeffrey D Jackson, Jeffrey P Jackson, Jeffrey Ojackson, Jeffery Jackson, Jeff Jackson, Jeffrey O'Jackson
Phone and address:
404 S Pitney Rd, Smithville, NJ 08205
(609) 404-7759
Related to:
Fariyd A Holmes, 38Lisa G Jackson, 63Gary R Holmes, 43Lance J Holmes, 66Estateofalber JacksonRandolph HolmesPaul L Jackson, 70Gina Y Holmes, 56Ramona W Holmes, 85Angelena JacksonRobert Jackson, 86Darren Holmes, 36James L Jackson, 85Lance Holmes, 38Marcus G Holmes, 34
Connected to:
A Jackson, 51Abena A Jackson, 53Abijah A Jackson, 40Abner P Jackson, 79Abraham L Jackson, 48Acelia A Jackson, 47Adiel W Jackson, 115Adiyba Jackson, 36Adria Jackson, 62Adriana M Jackson, 43

Jeffrey Jackson Phones & Addresses

  • 404 S Pitney Rd, Galloway, NJ 08205 (609) 404-7759 (609) 404-7756
  • Absecon, NJ
  • Durham, NC
  • Gloucester City, NJ
  • Pleasantville, NJ
  • Atlantic City, NJ
  • Camden, NJ
  • Atlantic Hl, NJ
  • 404 S Pitney Rd, Galloway, NJ 08205 (609) 404-7759

Work

Position: Professional/Technical

Education

Degree: High school graduate or higher

Professional Records

Lawyers & Attorneys

Jeffrey Jackson Photo 1

Jeffrey Jackson - Lawyer

View page
Office:
Law Office of Jeffrey B. Jackson
Specialties:
Criminal Defense
Sex Crime
Domestic Violence
DUI & DWI
Sex Crime
Criminal Law
ISLN:
916478597
Admitted:
2001
University:
University of Pennsylvania, B.A., 1996
Law School:
Santa Clara University School of Law, J.D., 2001
Jeffrey Jackson Photo 2

Jeffrey Jackson - Lawyer

View page
Specialties:
Real Estate
Commercial and Business Transactions
Mergers and Acquisitions
Corporate Law
Bankruptcy Law
ISLN:
901421607
Admitted:
1991
University:
Indiana University, B.A., 1988; Indiana University, B.A., 1988
Law School:
Indiana University, J.D., 1991; Indiana University, J.D., 1991
Jeffrey Jackson Photo 3

Jeffrey Jackson - Lawyer

View page
Office:
Law Office of Jeffrey C. Jackson
ISLN:
906230143
Admitted:
1982
University:
Chapman University, B.S.
Law School:
University of San Diego School of Law, J.D.
Jeffrey Jackson Photo 4

Jeffrey Jackson - Lawyer

View page
Office:
Law Office of Jeffrey B. Jackson
Specialties:
Criminal Defense
Sex Crime
Domestic Violence
DUI & DWI
Sex Crime
Criminal Law
ISLN:
916478597
Admitted:
2001
University:
University of Pennsylvania, B.A., 1996
Law School:
Santa Clara University School of Law, J.D., 2001
Jeffrey Jackson Photo 5

Jeffrey Jackson - Lawyer

View page
Office:
Scopelitis, Garvin, Light, Hanson & Feary, P.C.
Specialties:
Transportation
Labor and Employment
Corporate Law
Workers Compensation
Business Law
ISLN:
918644679
Admitted:
2005
University:
Indiana University, Bloomington, B.A., 2000
Law School:
Indiana Univeristy School of Law, J.D., 2005
Jeffrey Jackson Photo 6

Jeffrey Jackson - Lawyer

View page
Office:
Washburn University School of Law
Specialties:
Commercial Litigation
Trials and Appeals
Railroad
Administrative
Admitted:
1992
University:
Washburn University of Topeka, B.B.A., 1989
Law School:
Washburn University of Topeka, J.D., 1992

Resumes

Resumes

Jeffrey Jackson Photo 7

Jeffrey Jackson Township of Galloway, NJ

View page
Work:
Kmart Corporation

Jul 2014 to 2000
Backroom Specialist
The Richard Stockton College of New Jersey

Sep 2012 to 2000
Polling Institute Interviewer
United Way
Township of Galloway, NJ
Oct 2012 to Dec 2012
Peer Education Program
Township of Galloway, NJ
Jan 2011 to May 2011
William J. Hughes Technical Center
Atlantic City, NJ
2008 to Jun 2009
Inventory Control Specialist
Atlanticare
Township of Galloway, NJ
Mar 2009 to Mar 2009
Volunteer Assistant
Education:
The Richard Stockton College of New Jersey
Township of Galloway, NJ
May 2013
Bachelor of Science in Business Management
Jeffrey Jackson Photo 8

Jeffrey Jackson Fayetteville, NC

View page
Work:
K H SMITH

2006 to 2000
lead tech
NC Communications
Raleigh, NC
2004 to 2006
lead tech
Premise Cabling
Charlotte, NC
2002 to 2003
lead tech
Technologies Resolutions Eye and Ear Clinic and Hospital
Durham, NC
2001 to 2002
lead tech
Kmart Stores (Rollouts) Pioneer Data Comm
Charlotte, NC
1999 to 2001
tech
Westar Technologies UNC Charlotte
Charlotte, NC
1999 to 2000
tech
Nations Banks, Bank of America Network Cabling Systems
Charlotte, NC
1997 to 1999
tech
tech

1995 to 1997
6 cables for teller lines and office spaces
Communication Cables, Mecklenburg County Schools
Charlotte, NC
1991 to 1994
tech
Bennett-Hall Staffing, Network Communication, Burnup and Simms
Charlotte, NC
1990 to 1991
tech
National Security Service
Raleigh, NC
1988 to 1990
tech
Education:
PineCrest High School
Southern Pines, NC
1976 to 1978
Naval Telecommunications Schools

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mr. Jeffrey Jackson
President
Source 1, Inc
Source 1 Movers
Movers. Transportation Companies
6409 Fayetteville Rd STE 120 # 150, Durham, NC 27713
(877) 326-7701, (919) 875-4179
Jeffrey A. Jackson
President
Old Hickory Inc
Computersoftware Sts
3617 Silverside Rd, Wilmington, DE 19810
(302) 529-5760
Jeffrey Jackson
President
Software Shop Inc
Prepackaged Software Services
2905 Satori Way, Apex, NC 27539
Jeffrey Jackson
President
Source 1, Inc
Movers · Transportation Companies
6409 Fayetteville Rd STE 120 # 150, Durham, NC 27713
(877) 326-7701, (919) 875-4179
Jeffrey Jackson
Principal
Jeff Jackson Water & Gardens &
Landscape Services
42 W 7 Ave, Collegeville, PA 19426
Jeffrey Jackson
Executive Director
Fourjay Foundation
Charitable Grant Provider
2300 Computer Rd, Willow Grove, PA 19090
(215) 830-1437, (215) 830-1438
Jeffrey Jackson
Principal
Four J Foundation
Civic/Social Association · Other Social Advocacy Organizations · Non-Profit Organizations
2300 Computer Rd, Willow Grove, PA 19090
(215) 830-1400, (215) 830-1438
Jeffrey Jackson
Chief Executive Officer
Ambrix Inc
Software Engineering and Computer Consulting
404 S Pitney Rd, Smithville, NJ 08205

Publications

Us Patents

Human Pelota Homolog

View page
US Patent:
6342584, Jan 29, 2002
Filed:
Mar 10, 1999
Appl. No.:
09/265642
Inventors:
Jeffrey Richard Jackson - Collegeville PA
Michael Joseph Hansbury - Collingswood NJ
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07K 100
US Classification:
530350, 530 38
Abstract:
68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.

Use Of Csaid™ Compounds As Inhibitors Of Angiogenesis

View page
US Patent:
6372741, Apr 16, 2002
Filed:
Sep 8, 1998
Appl. No.:
09/142485
Inventors:
Jeffrey R. Jackson - Collegeville PA
James D. Winkler - Fort Washington PA
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 314178
US Classification:
5142358, 514252, 544122, 544123, 544316, 544331
Abstract:
The present invention is to the novel use of a cytokine inhibitor, which cytokine is inhibited by the inhibition of the kinase CSBP/p38/RK, for the treatment of chronic diseases which are caused by excessive, undesired or inappropriate angiogenesis.

Human Pelota Homolog

View page
US Patent:
6657047, Dec 2, 2003
Filed:
Dec 21, 2001
Appl. No.:
10/023895
Inventors:
Jeffrey Richard Jackson - Collegeville PA
Michael Joseph Hansbury - Collingswood NJ
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07K 1700
US Classification:
530350, 530380, 435 691
Abstract:
68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.

Use Of Csaidtm Compounds As Inhibitors Of Angiogenesis

View page
US Patent:
20020123500, Sep 5, 2002
Filed:
Mar 4, 2002
Appl. No.:
10/090010
Inventors:
Jeffrey Jackson - Collegeville PA, US
James Winkler - Fort Washington PA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K031/517
A61K031/506
A61K031/4439
A61K031/4709
US Classification:
514/256000, 514/266230, 514/341000, 514/307000, 514/314000, 514/394000, 514/397000
Abstract:
The present invention is to the novel use of a cytokine inhibitor for the treatment of chronic diseases which are caused by excessive, undesired or inappropriate angiogenesis.

Rhamm Antagonist Antibodies

View page
US Patent:
20020127227, Sep 12, 2002
Filed:
May 7, 2002
Appl. No.:
10/140555
Inventors:
Stephen Holmes - Great Chishill, GB
Julie Abrahamson - Harlow, GB
Jeffrey Jackson - Schwenksville PA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K039/395
C07H021/04
C07K016/30
US Classification:
424/143100, 530/388220, 536/023530
Abstract:
The present invention provides antagonist monoclonal antibodies to human RHAMM (receptor for hyaluronic acid mediated notility) and to the use of these monoclonal antibodies as therapeutics for the treatment of proliferative diseases.

Human Pelota Homolog

View page
US Patent:
20040096888, May 20, 2004
Filed:
Oct 6, 2003
Appl. No.:
10/678274
Inventors:
Jeffrey Jackson - Collegeville PA, US
Michael Hansbury - Collingswood NJ, US
Assignee:
SmithKline Beecham Corp. - Philadelphia PA
International Classification:
C12Q001/68
C07H021/04
C12N009/00
US Classification:
435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 536/023200
Abstract:
68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.

Differentially Expressed Nucleic Acids That Correlate With Ksp Expression

View page
US Patent:
20070015154, Jan 18, 2007
Filed:
Feb 13, 2004
Appl. No.:
10/544704
Inventors:
Priti Hedge - Collegeville PA, US
Pearl Huang - Collegeville PA, US
Jeffrey Jackson - Collegeville PA, US
Assignee:
SMITHKLINE BEECHAM CORPORATION - Philidelphia PA
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Nucleic acids that differentially expressed in certain tumors are provided. A variety of classification, screening, diagnostic and treatment methods are provided based upon these differentially expressed nucleic acids. Devices and kits for performing such methods are also disclosed.

Novel Compositions And Methods Of Treatment

View page
US Patent:
20070207996, Sep 6, 2007
Filed:
Aug 30, 2005
Appl. No.:
11/660460
Inventors:
Kurt Auger - Collegeville PA, US
Jeffrey Jackson - Collegeville PA, US
David Sutton - Collegeville PA, US
International Classification:
A61K 31/517
A61K 31/7072
A61K 31/704
A61K 31/282
A61K 31/4745
A61K 33/24
US Classification:
514210210, 514266200, 514266300, 514266220, 514034000, 514049000, 514492000, 514283000, 514449000, 424649000
Abstract:
Disclosed inter alia is the use of quinazolinone derivatives, which are modulators of a mitotic kinesin such as KSP, in the treatment of cellular proliferative diseases. The quinazolinone derivatives are administered with another chemotherapeutic agent selected from alkylating agents, antimetabolites, platinating agents, topoisomerase inhibitors, tubulin agents and signalling inhibitors (e.g., kinase inhibitors). Pharmaceutical compositions comprising one or both types of active agents are also disclosed.
Control profile
Jeffrey O Jackson from Galloway, NJ, age ~65 Get Report